Bioscience

TriSalus Life Sciences launches TriNav Infusion System to overcome infusion barriers in tumors

TriSalus Life Sciences launches TriNav Infusion System to overcome infusion barriers in tumors

DENVER -- TriSalus Life Sciences announced the launch of its TriNav Infusion System. Powered by its proprietary Pressure-Enabled Drug DeliveryTM (PEDD) approach with SmartValveTM technology,... Read More

Thursday January 16, 2020 0 comments Tags: Denver, TriSalus Life Sciences, Mary Szela

ArcherDX Personalized Cancer Monitoring (PCM) tech designated by FDA as Breakthrough Device

ArcherDX Personalized Cancer Monitoring (PCM) tech designated by FDA as Breakthrough Device

BOULDER -- ArcherDX, Inc. announced it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Personalized Cancer Monitoring (PCM) technology, a... Read More

Wednesday January 15, 2020 0 comments Tags: Boulder, ArcherDx, Jason Myers, FDA

Clovis Oncology’s Rubraca granted FDA priority review for advanced prostate cancer

Clovis Oncology’s Rubraca granted FDA priority review for advanced prostate cancer

BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the U.S. Food and Drug Administration (FDA) has accepted the companys supplemental New Drug Application (sNDA) for Rubraca ... Read More

Wednesday January 15, 2020 0 comments Tags: Boulder, Clovis Oncology, Patrick J. Mahaffey, Rubraca

PanTheryx announces new CEO and board chair

PanTheryx announces new CEO and board chair

BOULDER -- PanTheryx announced CEO Mark Braman is retiring and nutrition industry veteran Wes Parris, formerly of I-Health, Inc., will replace Braman as CEO effective immediately. PanTheryx... Read More

Tuesday January 14, 2020 0 comments Tags: Boulder, PanTheryx, Wes Parris, David Abramson, Mark Braman

ArcherDX and Illumina partner to broaden access for oncology testing

ArcherDX and Illumina partner to broaden access for oncology testing

BOULDER -- ArcherDX, Inc . announced a non-exclusive, multi-year partnership with San Diego-based Illumina, Inc. (NASDAQ: ILMN) that aims to broaden access of next generation sequencing (NGS)-based... Read More

Monday January 13, 2020 0 comments Tags: Boulder, ArcherDx, Jason Myers, Illumina, Phil Febbo

Cerebral Therapeutics completes $35M Series B financing round

Cerebral Therapeutics completes $35M Series B financing round

AURORA -- Cerebral Therapeutics , a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, today announced a$35 millionSeries B financing led... Read More

Tuesday January 7, 2020 0 comments Tags: Aurora, Cerebral Therapeutics, Dan Abrams

ArcherDX appoints Mark Massaro company CFO

ArcherDX appoints Mark Massaro company CFO

BOULDER -- ArcherDX, Inc. , a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has... Read More

Tuesday January 7, 2020 0 comments Tags: Boulder, ArcherDx, Mark Massaro, Jason Myers

Colorado life sciences companies raise $750M in 2019, Pfizer acquisition of Array BioPharma brings total to $12.1B

Colorado life sciences companies raise $750M in 2019, Pfizer acquisition of Array BioPharma brings total to $12.1B

DENVER -- Colorados life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of... Read More

Wednesday December 18, 2019 0 comments Tags: Denver, Colorado BioScience Association, Jennifer Jones Paton, Array BioPharma, Clovis Oncology, Inscripta, Emily Roberts